<DOC>
	<DOCNO>NCT02839421</DOCNO>
	<brief_summary>The aim present study evaluate clinical microbiological efficacy moxifloxacin amoxicillin plus metronidazole one-stage scaling root plan treat generalize aggressive periodontitis . Forty five subject randomly allocate 3 treatment group . Subgingival plaque sample analyse cultivable bacteria . The primary outcome variable determine superiority one treatment others would differences group mean CAL change 6 month post-treatment . Secondary outcome variable include difference therapy mean change mean level PD proportion BOP .</brief_summary>
	<brief_title>Efficacy Three Antibiotic Protocols Aggressive Periodontitis Treatment</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Aggressive Periodontitis</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Subjects ≤30 year age minimum six permanent teeth , least one site probe depth ( PD ) clinical attachment level ( CAL ) ≥5 mm minimum six teeth first molar incisor least one site PD CAL ≥5 mm . diabetes cardiovascular disease immunological disorder systemic disease could alter course periodontal disease . Pregnant nursing woman smoke allergy amoxicillin , metronidazole , fluoroquinolones moxifloxacin consumption systemic antimicrobial antiinflammatory drug last 6 month periodontal therapy last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>